Clinical Trial Execution, Live at the Biomarker Operations & Biospecimen Management Summit
Where Biomarker Strategy Meets Trial Execution
The science may define what needs to happen. Execution determines whether it does. Biomarker-enabled trials depend on complex, time-sensitive work across sites, labs, Clinical Operations, Translational teams, and external partners.
NOVEMBER 16-17 | BOSTON, MA
Schedule Time with Tru at the Biomarker Operations & Biospecimen Management Summit
We’d love to meet with you! Fill out the form and we’ll get back to you as soon as possible.
Designing for Execution: Bridging Scientific Ambition and Operational Reality in Biomarker-Enabled Trials
NOVEMBER 16 | 4:15 P.M. ET
Anu Ravi
Director, Clinical Operations
Revolution Medicines
Maria Gujral
Executive Director, Clinical Operations Capabilities & Standards
Legend Biotech
Benoit Destenaves
Head Senior Director, Oncology Translational Medicine Operations & Experimental Oncology
AstraZeneca
Moderated by Sherri Collins, Director of Project Management at TruTechnologies, this panel will explore:
- How biomarker operations can inform protocol design by bringing site feasibility, sample requirements, patient burden, and operational realities into the conversation earlier.
- How Translational, Biomarker Operations, Clinical Operations, laboratories, and CRO partners can better align around the end-to-end journey from sample collection through testing, analysis, and data delivery.
- What successful execution looks like, and how operational metrics, technology, and lessons learned can strengthen visibility, scalability, and biomarker delivery across studies.
Bridging the Gap Between Biomarker Strategy and Trial Execution
A strong biomarker strategy depends on reliable execution. Yet complex requirements, fragmented workflows, and limited visibility can put critical samples and data at risk.
Tru connects scientific intent to what happens at the site through three core capabilities:
- Turn Protocol Intent Into Execution
Dynamic protocol guidance helps sites perform required activities correctly, from sample collection through processing.
- Protect Samples at the Source
Live Data Capture™ preserves accuracy, timing, and context as activities happen, reducing downstream errors and reconciliation.
- See Risk While There's Still Time to Act
Live sponsor visibility helps teams identify execution issues early, before they compromise samples, data, or timelines.
Proven Impact of Going Live
“Increased visibility internally is a key win. The ability to see what was or wasn’t collected in real time has been transformational.”
What Can You Explore with Tru in Boston?
See how Tru connects protocol requirements with the realities of site and sample execution.
Our team can show you how Tru supports:
- Dynamic, protocol-guided site workflows
- Live Data Capture™ at the point of care
- Biological sample collection, processing, and traceability
- Immediate sponsor visibility into site execution
- Earlier issue detection and intervention
- Less rework and burden for sponsors and sites
Bring us a current biomarker, biospecimen, or trial execution challenge. We’ll show you what changes when execution becomes visible while the work is still happening.
Meet the Tru Team at the Biomarker Operations & Biospecimen Management Summit
Vimal Patel
Executive Director, Biotech
Collier Wright
Vice President, Solutions
Sherri Collins
Director, Project Management
Connect with our team to discuss how stronger execution can help bridge the gap between biomarker strategy, site operations, and the reliable delivery of samples and data.
Clinical Trial Execution.
Live. Visible. Actionable.
Biomarker Operations & Biospecimen Management Summit | NOVEMBER 16-17 | BOSTON, MA